TARDBP and amyotrophic lateral sclerosis: If TTBK1 or TTBK2 promote TDP-43 phosphorylation in patients with ALS or FTLD, there may be alterations in kinase abundance or localization, and there should be co-occurrence of the kinase with pathological TDP-43 aggregates.